Sponsor Pipeline

Alkeus Pharmaceuticals, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
1
Recruiting
1
Phase 3
Active Trials by Phase
Phase 3
1
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07419334 Study of ALK-001 on the Progression of Stargardt Disease Stargardt Disease Recruiting
Phase 2
NCT02402660 Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease Stargardt Disease Enrolling by Invitation
NCT04239625 Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE) Stargardt Disease Active, Not Recruiting
Get alerts when Alkeus Pharmaceuticals, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free